Imperial Brands 2030 Strategy: Driving Growth and Value Creation

Mar.27
Imperial Brands 2030 Strategy: Driving Growth and Value Creation
Imperial Brands unveils 2030 strategy to boost traditional tobacco and NGP business growth, focus on key markets for revenue increase.

Key points of focus:

Imperial Tobacco has released its 2030 strategy to drive growth in both traditional tobacco and new generation tobacco products (NGPs).

Focus on five major traditional tobacco markets, expand NGP business, and achieve net income growth.

Maintain the capital allocation framework, implement stock repurchases and a progressive dividend policy, and anticipate continued growth in financial indicators over the next five years.


On March 26th, Imperial Brands plc (referred to as "IMB") announced on its official website its 2030 strategy during Capital Markets Day. The strategy aims to achieve sustainable growth and long-term value creation over the next five years by strengthening its traditional tobacco business and expanding into Next Generation Products (NGP).

 

Focus on promoting traditional tobacco and new tobacco businesses.

 

The 2030 strategy of IBP will build on the successful foundation of its current five-year plan, focusing on five priority traditional tobacco markets (USA, Germany, UK, Spain, and Australia), which account for approximately 70% of IBP's adjusted tobacco operating profit. IBP will continue to advance in these markets to drive sustainable growth and cash flow.

 

In the field of Next Generation Products (NGP), IMB has established a rapidly growing and flexible business platform, encompassing credible brands and differentiated products in all three categories. IMB plans to expand its NGP business by further deepening consumer insights, leveraging differentiated brands, and developing sales capabilities.

 

Strengthening brand and organizational capabilities.

 

IBM will drive the achievement of its goals through the following three strategic elements:

 

Differentiated consumers and brand capability: Deepening insights into target groups, developing more differentiated and challenging brands, and innovating core needs. High-performance culture: Cultivating a culture of clear responsibilities, cross-regional collaboration, and long-term thinking, investing in leadership skills and improving business planning. Simplified, efficient, data-driven organization: Enhancing supply chain efficiency through global business services and excellence in manufacturing, utilizing data to support employee decision-making. Capital allocation framework and shareholder returns.

 

IBM will maintain its capital allocation framework, prioritizing organic growth in both traditional tobacco and NGP businesses, while keeping a strong and efficient balance sheet to support its investment grade credit rating. The company plans to return capital to shareholders through ongoing "evergreen" stock buyback programs, with the buyback amount determined by business performance. IBM will also continue its progressive dividend policy, providing reliable cash returns to shareholders.

 

Financial forecasts for the next five years.

 

IBM expects that its 2030 strategy will support the company in achieving the following mid-term growth targets (calculated at fixed exchange rates):

 

Tobacco and NGP Net Income: Net income from tobacco is expected to achieve low single-digit growth, while net income from NGPs is expected to achieve double-digit growth. Adjusted operating profit for the Group is expected to grow by around 3-5% annually. Adjusted Earnings Per Share (EPS) is expected to grow at a high single-digit rate, benefiting from ongoing stock buyback programs. Free cash flow is expected to generate £2.2 billion to £3 billion annually by the 2025 fiscal year.

 

British American Tobacco (BAT) has expressed confidence in achieving its full-year expectations for the 2025 fiscal year. The net revenue for tobacco and Next Generation Products (NGP) is expected to see low single-digit growth, with adjusted operating profit for the group nearing moderate single-digit growth, similar to last year. The NGP business is anticipated to achieve double-digit growth in net revenue for the full year. Adjusted earnings per share are expected to see high single-digit growth, despite increased financial and tax costs, with the share buyback program providing support. Adjusted operating profit for the group in the first half of the year is forecasted to grow by 1-2%, with adjusted earnings per share expected to grow in the moderate single-digit range. The tobacco business in the first half of the year will rely mainly on strong pricing power, maintaining overall market share in the five key markets, while NGP business is expected to see a net revenue growth of 10-15%. Performance in the second half of the year will be stronger due to tobacco pricing and investment phases. Exchange rate fluctuations are expected to have a negative impact of 2-3% on net revenue and adjusted operating profit in the first half of the year, and 1-2% for the full year.

 

IMB CEO Stefan Bomhard stated,

 

Our 2030 strategy outlines the choices we will make to strengthen our fuels and Next Generation Products (NGP) business, creating sustainable growth and long-term value for our shareholders. This strategy is built upon a solid foundation of our current plans, which have improved our business and delivered stronger, more consistent operational and financial performance, as well as outstanding returns for shareholders. This enhances my confidence that in the next five years, we will unlock more opportunities to create value.

 

We will maintain our unique challenger approach, which involves deeply understanding our consumers, enabling our employees to work flexibly, and focusing on our biggest growth opportunities. We will continue to enhance our capabilities, create differentiated brands, high-performance culture, and data-driven more efficient organization. This will support growth in combustibles, and we will continue to focus on the top five markets which account for approximately 70% of adjusted operating profit, as well as NGP. We will uphold our rigorous investment and market access standards.

 

“We maintain a strict capital allocation framework that supports investments in growth and delivers significant, growing returns to shareholders. We are committed to a progressive dividend per share and have announced today a 'evergreen' stock buyback program for the next five years. We believe that this combination of sustainable growth and capital returns provides shareholders with a compelling investment thesis.”

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | FASTA Nicotine Pouches Launch in U.S. with 22 Pouches per Can and 2 Nicotine Strengths
Product | FASTA Nicotine Pouches Launch in U.S. with 22 Pouches per Can and 2 Nicotine Strengths
A new product, FASTA NICOTINE POUCHES, has recently launched on U.S. vape distributor websites. Available in 6mg and 15mg nicotine strengths and six flavors, each can contains 22 pouches. Produced by UK-based REAZEN TECH LIMITED and marketed as “100% Made in Europe,” the product is currently priced at around $4.99.
May.14 by 2FIRSTS.ai
German Authorities Seize 45,000 Illegal E-Cigarettes in Cologne; Confiscated Products Resemble Fumot Devices
German Authorities Seize 45,000 Illegal E-Cigarettes in Cologne; Confiscated Products Resemble Fumot Devices
German customs in Cologne recently seized a batch of illegal e-cigarettes and e-liquids, totaling over 45,000 units with a market value exceeding 1 million euros. The confiscated products resemble those of the Fumot brand. This is the largest such case in the region in recent years.
Jun.12 by 2FIRSTS.ai
World No Tobacco Day 2025: Former WHO Executive Director Dr. Derek Yach Calls for Embracing Harm Reduction — A 2Firsts Exclusive
World No Tobacco Day 2025: Former WHO Executive Director Dr. Derek Yach Calls for Embracing Harm Reduction — A 2Firsts Exclusive
To mark World No Tobacco Day 2025, 2Firsts invited Dr. Derek Yach, former Executive Director at the World Health Organization, to share his reflections. In this article, Dr. Yach revisits the origins of WNTD during apartheid-era South Africa, its global rise, and its unfinished mission. He calls on the public health community to more fully embrace tobacco harm reduction and urges the WHO to take stronger leadership in supporting reduced-risk products.
May.29
Thai Police Bust Illegal E-Cigarette Factory, Arrest Chinese Kingpin and 28 Southeast Asian Workers in $170K Seizure
Thai Police Bust Illegal E-Cigarette Factory, Arrest Chinese Kingpin and 28 Southeast Asian Workers in $170K Seizure
Thai police busted an illegal e-cigarette factory in Pathum Thani Province, arresting 29 foreign nationals and seizing finished products and manufacturing equipment worth over $6 million.
Jun.30 by 2FIRSTS.ai
Product| ELFBAR BC Series Debuts 30,000-Puff Device with Interactive LEDs & Extended Battery
Product| ELFBAR BC Series Debuts 30,000-Puff Device with Interactive LEDs & Extended Battery
ELFBAR's newly launched BC30000 features a 30,000-puff capacity powered by a 1100mAh battery. Its interactive LED screen displays animated emoticons with each puff while providing real-time e-liquid and battery status indicators.
Jun.30 by 2FIRSTS.ai
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
The U.S. Food and Drug Administration has officially launched Elsa, a generative AI tool designed to speed up clinical reviews, internal writing, and data processing tasks. After successful pilots across multiple departments, Elsa is now being rolled out agency-wide.
Jun.04 by 2FIRSTS.ai